Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
7,168,178
-
Share change
-
+1,160,520
-
Total reported value
-
$2,029,120
-
Put/Call ratio
-
0%
-
Price per share
-
$0.28
-
Number of holders
-
22
-
Value change
-
+$383,888
-
Number of buys
-
15
-
Number of sells
-
5
Institutional Holders of INTEC PHARMA LTD JERUSALEM - SHS as of Q2 2020
As of 30 Jun 2020,
INTEC PHARMA LTD JERUSALEM - SHS was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,168,178 shares.
The largest 10 holders included
MEITAV DASH INVESTMENTS LTD, ADAGE CAPITAL PARTNERS GP, L.L.C., RENAISSANCE TECHNOLOGIES LLC, AdvisorShares Investments LLC, Integrated Wealth Concepts LLC, Harel Insurance Investments & Financial Services Ltd., CITADEL ADVISORS LLC, Squarepoint Ops LLC, Russell Investments Group, Ltd., and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
22
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.